As of 2024-12-14, the Relative Valuation of Eagle Pharmaceuticals Inc (EGRX) is 117.90 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.14 USD, the upside of Eagle Pharmaceuticals Inc based on Relative Valuation is 5409.4%.
The range of the Relative Valuation is 56.63 - 173.72 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.1x - 36.2x | 34.4x |
| Forward P/E multiples | 24.4x - 35.8x | 32.0x |
| Fair Price | 56.63 - 173.72 | 117.90 |
| Upside | 2546.0% - 8017.9% | 5409.4% |
| Date | P/E |
| 2024-12-11 | 0.29 |
| 2024-12-10 | 0.36 |
| 2024-12-09 | 0.36 |
| 2024-12-06 | 0.36 |
| 2024-12-05 | 0.38 |
| 2024-12-04 | 0.38 |
| 2024-12-03 | 0.33 |
| 2024-12-02 | 0.32 |
| 2024-11-29 | 0.30 |
| 2024-11-27 | 0.30 |
| 2024-11-26 | 0.41 |
| 2024-11-25 | 0.35 |
| 2024-11-22 | 0.40 |
| 2024-11-21 | 0.38 |
| 2024-11-20 | 0.28 |
| 2024-11-19 | 0.28 |
| 2024-11-18 | 0.38 |
| 2024-11-15 | 0.28 |
| 2024-11-14 | 0.30 |
| 2024-11-13 | 0.32 |
| 2024-11-12 | 0.38 |
| 2024-11-11 | 0.36 |
| 2024-11-08 | 0.36 |
| 2024-11-07 | 0.36 |
| 2024-11-06 | 0.34 |
| 2024-11-05 | 0.34 |
| 2024-11-04 | 0.21 |
| 2024-11-01 | 0.23 |
| 2024-10-31 | 0.26 |
| 2024-10-30 | 0.21 |
| 2024-10-29 | 0.17 |
| 2024-10-28 | 0.15 |
| 2024-10-25 | 0.26 |
| 2024-10-24 | 0.28 |
| 2024-10-23 | 0.27 |
| 2024-10-22 | 0.30 |
| 2024-10-21 | 0.30 |
| 2024-10-18 | 0.38 |
| 2024-10-17 | 0.28 |
| 2024-10-16 | 0.34 |
| 2024-10-15 | 0.26 |
| 2024-10-14 | 0.26 |
| 2024-10-11 | 0.37 |
| 2024-10-10 | 0.26 |
| 2024-10-09 | 0.40 |
| 2024-10-08 | 0.23 |
| 2024-10-07 | 0.28 |
| 2024-10-04 | 0.38 |
| 2024-10-03 | 0.85 |
| 2024-10-02 | 0.91 |